Zhejiang Shengda Bio-Pharm Co., Ltd. (SHA:603079)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Vitamins	244.71M			411.15M	604.71M	-	-
Vitamins Growth	-			-32.01%	-	-	-
Biological Preservative	489.31M			274.45M	217.46M	-	-
Biological Preservative Growth	-			26.20%	-	-	-
External Steam Sales	37.19M			-	-	-	-
Others	56.18M			104.14M	45.14M	14.89M	7.25M
Others Growth	-			130.71%	203.21%	105.48%	766.71%
Biotin	-			-	-	254.57M	251.31M
Biotin Growth	-			-	-	1.29%	-15.54%
Nisin	-			-	-	122.66M	113.32M
Nisin Growth	-			-	-	8.25%	28.94%
Folic acid	-			-	-	54.32M	58.44M
Folic acid Growth	-			-	-	-7.05%	-22.87%
Natamycin	-			-	-	42.43M	40.65M
Natamycin Growth	-			-	-	4.38%	1.39%
Polylysine	-			-	-	28.65M	21.36M
Polylysine Growth	-			-	-	34.13%	268.03%
Total	827.40M			789.73M	867.31M	517.51M	492.33M
Total Growth	-			-8.95%	67.59%	5.12%	-3.08%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
China	591.11M			434.36M	380.99M	235.66M	209.09M
China Growth	-			14.01%	61.67%	12.70%	8.40%
Overseas	236.29M			355.37M	486.33M	281.86M	283.23M
Overseas Growth	-			-26.93%	72.54%	-0.49%	-10.10%
Total	827.40M			789.73M	867.31M	517.51M	492.33M
Total Growth	-			-8.95%	67.59%	5.12%	-3.08%

Source: S&P Global Market Intelligence.